Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

170.81
+2.651.58%
Post-market: 170.80-0.0100-0.01%19:59 EDT
Volume:7.05M
Turnover:1.20B
Market Cap:44.07B
PE:-12.01
High:171.04
Open:167.73
Low:167.52
Close:168.16
52wk High:176.60
52wk Low:141.05
Shares:258.02M
Float Shares:258.02M
Volume Ratio:0.84
T/O Rate:2.73%
Dividend:2.45
Dividend Rate:1.43%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.28
PE(LYR):-12.01

Loading ...

Exchange-Traded Funds, Equity Futures Up Pre-Bell Friday as Oil Prices Fall, Traders Assess SpaceX Spectrum Deal

MT Newswires Live
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), United Therapeutics (UTHR) and Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Yesterday

Merck & Company (MRK) Receives a Buy from UBS

TIPRANKS
·
Yesterday

Alignment Healthcare Price Target Cut to $12.00/Share from $28.00 by Keybanc

Dow Jones
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC), Veeva Systems (VEEV) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
Yesterday

UnitedHealth price target lowered to $402 from $430 at TD Cowen

TIPRANKS
·
Yesterday

Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Tilray (TLRY) and Viatris (VTRS)

TIPRANKS
·
Yesterday

U.S. Stocks on the MOVE-SpaceX, Humana, Delta Air Lines

Reuters
·
Yesterday

Piper Sandler recommends buying UnitedHealth on 2027 Star Ratings release

TIPRANKS
·
Yesterday

Analysts’ Top Healthcare Picks: Biohaven Ltd. (BHVN), Clover Health Investments (CLOV)

TIPRANKS
·
Yesterday

William Blair Downgrades Alignment Healthcare to Market Perform From Outperform

MT Newswires Live
·
Yesterday

Alignment Healthcare price target lowered to $10 from $22 at JPMorgan

TIPRANKS
·
Yesterday

Johnson & Johnson reports new two-year results from Phase 3 ICONIC-LEAD study

TIPRANKS
·
Yesterday

J&J Says Phase 3 Iconic-LEAD Trial Shows Icotyde Sustains Plaque Psoriasis Clearance Through 2 Years

Reuters
·
Yesterday

J&J - at Week 112, 72% Achieve Pasi 90, 70% Achieve Iga 0/1 with Icotyde

THOMSON REUTERS
·
Yesterday

J&J - no New Safety Signals Identified for Icotyde Through Week 112

THOMSON REUTERS
·
Yesterday

New Johnson & Johnson Icotyde® (Icotrokinra) Long-Term Data Demonstrate Robust 2-Year Results in the Treatment of Adults and Adolescents with Plaque Psoriasis

THOMSON REUTERS
·
Yesterday

Eli Lilly announces new TOGETHER-PsO trial data

TIPRANKS
·
Yesterday

Merck price target lowered to $163 from $166 at BofA

TIPRANKS
·
Yesterday

Alignment Healthcare Sees Lowered Federal Rating for California Health Plan; Shares Fall Pre-Bell

MT Newswires Live
·
Yesterday